| Patent No. | Patent Title: |
| 6255113 | Homologous sequence targeting in eukaryotic cells |
| 6251957 | Method of reducing an immune response to a recombinant virus |
| 6218597 | Transgenic model and treatment for heart disease |
| 6203977 | Delineation of individual human chromosomes in metaphase and inte... |
| 6201165 | Transgenic animal models for cardiac hypertrophy and methods of u... |
| 6194635 | Embryonic germ cells, method for making same, and using the cells... |
| 6187991 | Transgenic animal models for type II diabetes mellitus |
| 6180613 | AAV-mediated delivery of DNA to cells of the nervous system |
| 6177410 | Therapeutic methods for prostate cancer |
| 6172047 | Method of screening candidate protective, potentiating, or inhibi... |
| 6172278 | Ikaros transgenic cells and mice |
| 6166288 | Method of producing transgenic animals for xenotransplantation ... |
| 6166287 | Corticotropin-releasing factor overproducing transgenic mice |
| 6159680 | Assay for pharmacological agents that block neurofibromin action |
| 6159947 | Anti-RAS intracellular binding proteins and use thereof |
| 6159948 | Therapeutic and drug screening methods for the treatment and prev... |
| 6156952 | HIV transgenic animals and uses therefor |
| 6156306 | Pancreatic ଲ-cells for allogeneic transplantation without ... |
| 6153427 | Erythropoietin-inducible, erythroid-specific DNA construct |
| 6153409 | Process for continuous optimized protein production in insect lar... |
| 6150160 | Compositions and methods of use of mammalian retrotransposons |
| 6150170 | Method for introducing and expressing genes in animal cells, and ... |
| 6146623 | In vitro-derived genetically altered human neutrophil precursor c... |
| 6139835 | Homologous recombination for allogeneic donor cells |
| 6140060 | Cloned lysophosphatidic acid receptors |
| 6137029 | PEPCK-insulin gene construct and transgenic mouse |
| 6136594 | Replication deficient recombinant adenovirus vector |
| 6136040 | Animal model with disrupted FGF-9 gene |
| 6127598 | NKX-2.2 and NKX-6.1 transgenic mouse models for diabetes, depress... |
| 6120764 | Adenoviruses for control of gene expression |
| 6121246 | Method for treating ischemic tissue |
| 6114599 | Recombinant ଲ-cell and uses thereof |
| 6107543 | Culture of totipotent embryonic inner cells mass cells and produc... |
| 6096716 | Liposome-mediated transfection of central nervous system cells |
| 6090790 | Gene delivery by microneedle injection |
| 6090608 | SV-40 derived DNA constructs comprising exogenous DNA sequences |
| 6077990 | PAR2 modified transgenic mice |
| 6069010 | High throughput gene inactivation with large scale gene targeting |
| 6066502 | Endothelin converting enzyme (ECE) |
| 6066778 | Transgenic mice expressing APC resistant factor V |
Quotables 
PatentStorm News
